Overall rank by patents
#26,782
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
MALLINCKRODT NUCLEAR MEDICINE LLC
USPTO PatentsView assignee record — 10 granted patents across 16 technology areas, active 2016–2019. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G21G (CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES).
10
Total patents granted
16
CPC technology areas
20.0
Avg claims per patent
-100%
5-year filing velocity
Portfolio overview
MALLINCKRODT NUCLEAR MEDICINE LLC has been granted 10 US utility patents between 2016 and 2019, placing MALLINCKRODT NUCLEAR MEDICINE LLC at rank #26,782 across all assignees tracked by PlainPatent. This portfolio spans 16 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.0 claims per patent with primary concentration in G21G (CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES). As a US Corporation, MALLINCKRODT NUCLEAR MEDICINE LLC is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 34.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 10 in the 2015–2019 window — a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. MALLINCKRODT NUCLEAR MEDICINE LLC's 20.0 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 16 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark MALLINCKRODT NUCLEAR MEDICINE LLC against peers pursuing similar technology classes.
How does MALLINCKRODT compare?
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- Mallinckrodt Nucl… ◀ 10
MALLINCKRODT NUCLEAR MEDICINE LLC
10 patents
What this shows MALLINCKRODT holds 10 patents — placing it at rank #26,782 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
USPTO utility patent grants by year · 2016–2019
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 10.0% |
| 2017 | 2 | 20.0% |
| 2018 | 5 | 50.0% |
| 2019 | 2 | 20.0% |
Which technologies does MALLINCKRODT NUCLEAR MEDICINE LLC patent most?
B65B— MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING 2
Top 15 of 16 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex
Velocity Declining
Frequently Asked Questions
How many patents does MALLINCKRODT NUCLEAR MEDICINE LLC hold?
MALLINCKRODT NUCLEAR MEDICINE LLC holds 10 US granted patents filed between 2016 and 2019, spanning 16 technology areas.
What is MALLINCKRODT NUCLEAR MEDICINE LLC's Innovation Score?
MALLINCKRODT NUCLEAR MEDICINE LLC has an Innovation Score of 34.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does MALLINCKRODT NUCLEAR MEDICINE LLC focus on?
MALLINCKRODT NUCLEAR MEDICINE LLC's top technology area is G21G (CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES) with 7 patents. The company has filed patents in 16 CPC subclasses total.
Is MALLINCKRODT NUCLEAR MEDICINE LLC's patent filing rate increasing or decreasing?
MALLINCKRODT NUCLEAR MEDICINE LLC's recent filing velocity is -100% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for MALLINCKRODT NUCLEAR MEDICINE LLC's patents?
MALLINCKRODT NUCLEAR MEDICINE LLC's patents average 20.0 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the MALLINCKRODT NUCLEAR MEDICINE LLC patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Learn More
Explore the patent dataset
G21G technology
MALLINCKRODT NUCLEAR MEDICINE LLC's primary CPC class — all holders and yearly trends
Top 50 patent holders
See where MALLINCKRODT NUCLEAR MEDICINE LLC ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
- USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
- USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
- USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
- SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
- WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope
